Aktis Oncology, Inc. (AKTS)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Insider purchase
    EcoR1 Capital, LLC; NODELMAN OLEG (director) bought $37.4M of stock
  3. Insider purchase
    NODELMAN OLEG (director) bought $37.4M of stock
  4. Insider buying cluster
    6 insiders bought $114.3M within 14 days
  5. Insider purchase
    GADICKE ANSBERT (ten_percent_owner) bought $20.0M of stock
  6. Insider purchase
    GADICKE ANSBERT; MPM ASSET MANAGEMENT LLC; Oncology Impact Private Investment Fund 2, L.P. (ten_percent_owner) bought $20.0M of stock
  7. Insider purchase
    MPM ONCOLOGY INNOVATIONS FUND LP (ten_percent_owner) bought $20.0M of stock
  8. Insider purchase
    Kim Helen Susan (director) bought $14.6M of stock
  9. Insider purchase
    VIDA VENTURES II-A, LLC (ten_percent_owner) bought $14.6M of stock
  10. Insider purchase
    Foley Todd (director) bought $4.2M of stock
  11. Insider purchase
    Foley Todd (director) bought $4.2M of stock
  12. Insider purchase
    NODELMAN OLEG (director) bought $2.6M of stock
  13. Insider purchase
    VIDA VENTURES II-A, LLC (ten_percent_owner) bought $406k of stock
  14. Insider purchase
    Kim Helen Susan (director) bought $406k of stock

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-07-20Herrmann KendirectorM3,5060.08$280
2026-07-20Herrmann KendirectorM1,3501.91$2,579
2026-07-20Herrmann KendirectorS3,50624.56$86,115
2026-07-20Herrmann KendirectorS1,35024.56$33,159
2026-07-17Herrmann KendirectorM3,0650.08$245
2026-07-17Herrmann KendirectorS3,06525.21$77,259
2026-07-08Ron-Bigger ShulamitofficerM50,0003.66$183,000
2026-07-08Ron-Bigger ShulamitofficerS15,80027.13$428,681
2026-07-08Ron-Bigger ShulamitofficerS30,00027.94$838,137
2026-07-08Ron-Bigger ShulamitofficerS4,20028.75$120,740
2026-07-08Czibere AkosofficerM50,0004.95$247,500
2026-07-08Czibere AkosofficerS14,80027.13$401,484
2026-07-08Czibere AkosofficerS30,82927.95$861,735
2026-07-08Czibere AkosofficerS4,37128.71$125,482
2026-01-12Foley TodddirectorC2,688,270——
2026-01-12Foley TodddirectorP232,87018$4,191,660
2026-01-12Foley TodddirectorC597,391——
2026-01-12Foley TodddirectorC716,872——
2026-01-12MPM ONCOLOGY INNOVATIONS FUND LPten percent ownerC1,577,119——
2026-01-12MPM ONCOLOGY INNOVATIONS FUND LPten percent ownerC5,914,197——
2026-01-12MPM ONCOLOGY INNOVATIONS FUND LPten percent ownerC1,314,262——
2026-01-12MPM ONCOLOGY INNOVATIONS FUND LPten percent ownerP1,112,77718$20,029,986
2026-01-12GADICKE ANSBERTten percent ownerC1,314,262——
2026-01-12GADICKE ANSBERTten percent ownerP1,112,77718$20,029,986
2026-01-12GADICKE ANSBERTten percent ownerC1,577,119——
2026-01-12GADICKE ANSBERTten percent ownerC5,914,197——
2026-01-12NODELMAN OLEGdirectorP2,077,77918$37,400,022
2026-01-12NODELMAN OLEGdirectorC128,506——
2026-01-12NODELMAN OLEGdirectorC202,862——
2026-01-12NODELMAN OLEGdirectorC2,270,879——
2026-01-12NODELMAN OLEGdirectorP144,44318$2,599,974
2026-01-12VIDA VENTURES II-A, LLCten percent ownerC4,859,370——
2026-01-12VIDA VENTURES II-A, LLCten percent ownerP22,54518$405,810
2026-01-12VIDA VENTURES II-A, LLCten percent ownerC134,842——
2026-01-12VIDA VENTURES II-A, LLCten percent ownerP812,45518$14,624,190
2026-01-12Segal Lloyd MitchelldirectorC19,631——
2026-01-12Kim Helen SusandirectorC4,859,370——
2026-01-12Kim Helen SusandirectorP22,54518$405,810
2026-01-12Kim Helen SusandirectorC134,842——
2026-01-12Kim Helen SusandirectorP812,45518$14,624,190
2026-01-12Foley TodddirectorC597,391——
2026-01-12Foley TodddirectorC2,688,270——
2026-01-12Foley TodddirectorC716,872——
2026-01-12Foley TodddirectorP232,87018$4,191,660
2026-01-12MPM BIOVENTURES 2018, L.P.; EVNIN LUKE; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2018 LLC; MPM BioVentures 2018 GP LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM ONCOLOGY INNOVATIONS FUND LP; MPM Oncology Innovations Fund GP LLCten percent ownerC1,314,262——
2026-01-12MPM BIOVENTURES 2018, L.P.; EVNIN LUKE; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2018 LLC; MPM BioVentures 2018 GP LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM ONCOLOGY INNOVATIONS FUND LP; MPM Oncology Innovations Fund GP LLCten percent ownerC5,914,197——
2026-01-12MPM BIOVENTURES 2018, L.P.; EVNIN LUKE; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2018 LLC; MPM BioVentures 2018 GP LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM ONCOLOGY INNOVATIONS FUND LP; MPM Oncology Innovations Fund GP LLCten percent ownerC1,577,119——
2026-01-12MPM BIOVENTURES 2018, L.P.; EVNIN LUKE; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2018 LLC; MPM BioVentures 2018 GP LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM ONCOLOGY INNOVATIONS FUND LP; MPM Oncology Innovations Fund GP LLCten percent ownerP1,112,77718$20,029,986
2026-01-12GADICKE ANSBERT; MPM ASSET MANAGEMENT LLC; Oncology Impact Private Investment Fund 2, L.P.ten percent ownerC1,314,262——
2026-01-12GADICKE ANSBERT; MPM ASSET MANAGEMENT LLC; Oncology Impact Private Investment Fund 2, L.P.ten percent ownerC5,914,197——

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings